Edgen Stock·Sep 25 2025, 17:13戻る
戻る
Eli Lilly Discontinues Specific Bimagrumab Obesity Drug Trial
Edgen Stock·Sep 25 2025, 17:13
[1] Lilly stops trial of muscle-sparing obesity drug (https://www.biopharmadive.com/news/lilly-term ...)[2] Eli Lilly's Bimagrumab Halt: Rethinking Innovation and Investor Confidence in Obesity Therapeutics - AInvest (https://vertexaisearch.cloud.google.com/groun ...)[3] Lilly stops trial of muscle-sparing obesity drug - BioPharma Dive (https://vertexaisearch.cloud.google.com/groun ...)